The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Enrolling study subjects, setting up patient randomization and managing drug supply are critical to the success of a clinical trial.

Clinical Supply 52

Clinical Supply Clinical Supply Chain Doctors Doctor 52

Pharmaceutical Technology

SEPTEMBER 20, 2022

The list includes clinical packaging service contractors with expertise in material science, industrial design and information technology and providing innovative and cost-effective clinical trial packaging solutions.

Packaging 100

Packaging Packaging Marketing Clinical Trials 100

The Pharma Data

JANUARY 24, 2021

Food and Drug Administration (“FDA”) approval. Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally derived compound for the potential treatment of cancer, neurological, inflammatory and infectious diseases.

Drugs 52

Drugs Containment Development Sales 52

XTalks

APRIL 6, 2023

IRT solutions help clinical trial sponsors meet the complexities of patient randomization and clinical supply management. IRT development is a very risk-averse business because IRT systems randomize patients and determine what investigational drug is administered to a participant, among other things.

Clinical Trials 98

Clinical Trials Clinical Trials Clinical Supply Trials 98

Client Pharma

DECEMBER 13, 2021

Collaboration provides clinical trial sponsors with access to the world’s most efficient clinical supply processes using a single contract. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers.

Clinical Supply 52

Clinical Supply Clinical Trials Clinical Trials Life Science 52

The Pharma Data

OCTOBER 27, 2020

The collaboration aims to leverage Molecular Partners’ proprietary DARPin® technologies and Novartis’ broad expertise in global drug development, regulatory affairs, manufacturing and commercialization to rapidly advance the program in keeping with the unprecedented global urgency created by the pandemic.

Development 52

Development Protein Manufacturing Medicine 52

Pharmaceutical Technology

MAY 23, 2023

Oncology was the main therapy area, accounting for 218 trials, followed by central nervous system drugs having 185, and infectious diseases next with 138. Multinational clinical trials dominated the total with 95% at 1,119, compared with 58 for single-country trials – or just under 5%. Credit: Oximio.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Clinical Supply Chain 130